Principal Investigator
Juan Alderuccio
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20230567
Clinical Trial Summary
A phase I, open-label, multi-center study of PIT565 in patients with relapsed and/or refractory B-cell malignancies
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Lymphoma
Contact Information
Phone Number
305-243-2647